MKI67 and neoplasm: Third, based on the measurements of proliferation by Ki67 in primary colon cancers (n = 92) and xenograft tumors (Supplementary Fig. 6), growth rates in our model were slowed to 0.5 in central tumor areas relative to the leading tumor edge.